March 24, 2022 Comments Off on New patent for Pfizer drug XELJANZ XR Posted in: Patent Added Annual Drug Patent Expirations for XELJANZ+XR Xeljanz Xr is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are four patents…
The post New patent for Pfizer drug XELJANZ XR appeared first on DrugPatentWat…
March 24, 2022 Comments Off on New patent for Boehringer Ingelheim drug JARDIANCE Posted in: Patent Added Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from four suppliers. There are seven patents…
The post New patent for Boehringer Ingelheim drug JARDIANCE appe…
